PD-L1(+) lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients

por Raniszewska, A., Vroman, H., Dumoulin, D., Cornelissen, R., Aerts, J. G. J. V., Domagała-Kulawik, J.
Publicado 2020

Reliability and validity of the Cancer Therapy Satisfaction Questionnaire in lung cancer

por Cheung, K., de Mol, M., Visser, S., Den Oudsten, B. L., Stricker, B. H., Aerts, J. G. J. V.
Publicado 2015

Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study

por Surmont, V., Aerts, J. G. J. V., Tan, K. Y., Schramel, F., Vernhout, R., Hoogsteden, H. C., van Klaveren, R. J.
Publicado 2009

Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis

por Pieters, A., Bakker, M., Hoek, R. A. S., Altenburg, J., van Westreenen, M., Aerts, J. G. J. V., van der Eerden, M. M.
Publicado 2019

Optical Detection of Preneoplastic Lesions of the Central Airways

por van der Leest, C., Amelink, A., van Klaveren, R. J., Hoogsteden, H. C., Sterenborg, H. J. C. M., Aerts, J. G. J. V.
Publicado 2012

Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles

por Visser, S., Hou, J., Bezemer, K., de Vogel, L. L., Hegmans, J. P. J. J., Stricker, B. H., Philipsen, S., Aerts, J. G. J. V.
Publicado 2019

New Roads Open Up for Implementing Immunotherapy in Mesothelioma

por Cornelissen, R., Heuvers, M. E., Maat, A. P., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G. J. V., Hegmans, J. P. J. J.
Publicado 2012

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

por Moor, C. C., Mostard, R. L. M., Grutters, J. C., Bresser, P., Aerts, J. G. J. V., Dirksen, C. D., Kimman, M. L., Wijsenbeek, M. S.
Publicado 2020

The smell of lung disease: a review of the current status of electronic nose technology

por van der Sar, I. G., Wijbenga, N., Nakshbandi, G., Aerts, J. G. J. V., Manintveld, O. C., Wijsenbeek, M. S., Hellemons, M. E., Moor, C. C.
Publicado 2021

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

por Veltman, J D, Lambers, M E H, van Nimwegen, M, Hendriks, R W, Hoogsteden, H C, Hegmans, J P J J, Aerts, J G J V
Publicado 2010

Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making

por Mokhles, S., Nuyttens, J. J. M. E., de Mol, M., Aerts, J. G. J. V., Maat, A. P. W. M., Birim, Ö., Bogers, A. J. J. C., Takkenberg, J. J. M.
Publicado 2018

Towards the Optical Detection of Field Cancerization in the Buccal Mucosa of Patients with Lung Cancer()()

por Bugter, O., van Brummelen, S.E., van der Leest, K.H., Aerts, J.G.J.V., Maat, A.P.W.M., Baatenburg de Jong, R.J., Amelink, A., Robinson, D.J.
Publicado 2019

Return to work and health-related quality of life up to 1 year in patients hospitalized for COVID-19: the CO-FLOW study

por Bek, L. M., Berentschot, J. C., Hellemons, M. E., Remerie, S. C., van Bommel, J., Aerts, J. G. J. V., Ribbers, G. M., van den Berg-Emons, H. J. G., Heijenbrok-Kal, M. H.
Publicado 2023

The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer

por Banna, G.L., Cortellini, A., Cortinovis, D.L., Tiseo, M., Aerts, J.G.J.V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Di Marino, P., Mansueto, G., Zoratto, F., Filetti, M., Montrone, M., Citarella, F., Marco, R., Cantini, L., Nigro, O., D'Argento, E., Buti, S., Minuti, G., Landi, L., Guaitoli, G., Lo Russo, G., De Toma, A., Donisi, C., Friedlaender, A., De Giglio, A., Metro, G., Porzio, G., Ficorella, C., Addeo, A.
Publicado 2021

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-ce...

por Banna, G.L., Cortellini, A., Cortinovis, D.L., Tiseo, M., Aerts, J.G.J.V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Di Marino, P., Mansueto, G., Zoratto, F., Filetti, M., Montrone, M., Citarella, F., Marco, R., Cantini, L., Nigro, O., D'Argento, E., Buti, S., Minuti, G., Landi, L., Guaitoli, G., Lo Russo, G., De Toma, A., Donisi, C., Friedlaender, A., De Giglio, A., Metro, G., Porzio, G., Ficorella, C., Addeo, A.
Publicado 2021